Serum amyloid A: a novel biomarker for endometrial cancer. - Wikidata - awgldk - TriplyDB

Serum amyloid A: a novel biomarker for endometrial cancer.

Serum amyloid A: a novel biomarker for endometrial cancer.

http://www.wikidata.org/entity/Q33643221

about

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis.Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma Inflammatory serum proteins are severely altered in metastatic gastric adenocarcinoma patients from the Chinese population Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study Serum amyloid A: A new potential serum marker correlated with the stage of breast cancer.The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer.MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment.Serum biomarkers for early detection of gynecologic cancers.Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis.Expression of serum amyloid A in uterine cervical cancer.Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer.Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.Proteomics of endometrial cancer diagnosis, treatment, and prognosis.Serum amyloid A induces mitogenic signals in regulatory T cells via monocyte activation.Amyloidosis and the risk of cancer: a nationwide population-based study.The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients.Plasma proteomics analysis of tamoxifen resistance in breast cancer.Fourier-transform infrared spectroscopy coupled with a classification machine for the analysis of blood plasma or serum: a novel diagnostic approach for ovarian cancer.Serum amyloid A1 is upregulated in human glioblastoma.Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.Systemic AA amyloidosis in a patient with lung metastasis from renal cell carcinoma.Serum amyloid a protein in clinical cancer diagnosis.The crucial roles of inflammatory mediators in inflammation: A review.

P2860

Q33587249-D760AAB1-2EEE-4D3E-839C-72C079D394AA Q33604867-81749BDF-01B3-49D5-A1F7-FCF06C9E0684 Q34216967-650A4403-A3BE-4F19-96C5-FF1951CA782A Q34260081-C5D49A73-47C8-4E3A-A5DE-D602F617D040 Q34392042-3369279E-4FDF-4FA2-8BCD-C504C40B43C0 Q35464730-6EF4AB14-5CF0-4EC9-A2F7-76A232F24B95 Q35777594-47C36C19-56D2-4321-907D-88F12FE4CB56 Q35995489-19D3E769-9563-4812-AECA-CB4285F1E494 Q36121363-AD1559EE-5617-4F76-8721-B5777B0F3073 Q36147848-C64F5AF0-0844-4A17-BCE3-BBB9A6E18DA0 Q37328423-B31EC9EA-F0A8-4920-A4A4-4362717CB20D Q37392583-8EB77366-403E-4F31-B5DF-4AD7BEEBC478 Q37534891-DFF05493-96C3-4659-B9DA-A66F75FFF97B Q37619708-3035C959-102D-484C-896F-86399434D7F6 Q37699264-72DC9F79-518C-49DF-A918-B4966D60DE9E Q37745875-2B096692-998F-4D6C-849F-93C40DB361B9 Q37960202-5C8FB389-14CD-49A3-B53D-BA217B26A0FF Q38626386-9CAB970D-6EDF-4BA1-8858-DB6DCABEB7D4 Q41072807-89A1CC4A-9EAF-4B2C-AE52-60FFD9B5C1FC Q41695607-9B903E62-0646-4E94-A5E5-C3213A7BBCD0 Q44259160-C29C2E37-6695-4E52-8476-55EB55CFE7C0 Q44493749-00BD28C1-890D-4A5F-B9B2-0F8106F2E87F Q47260271-47E28E5E-8D70-4962-A74D-D565B3350E36 Q48137968-D68D7482-23B3-454C-AFEF-7E6D0BD3671D Q52598780-4459CB12-9FA2-447C-B70A-7323DAD562FB Q53149012-D8DF2E41-E4F6-4900-9070-B3386656477A Q53282038-734FE1BE-B511-4778-83E8-21ECD1A0216F Q55338907-E0E78B04-CFEB-421B-AF9D-D304E8D8E1CF

P2860

Serum amyloid A: a novel biomarker for endometrial cancer.

http://www.wikidata.org/entity/Q33643221

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Serum amyloid A: a novel biomarker for endometrial cancer.

@ast

Serum amyloid A: a novel biomarker for endometrial cancer.

@en

type

label

Serum amyloid A: a novel biomarker for endometrial cancer.

@ast

Serum amyloid A: a novel biomarker for endometrial cancer.

@en

prefLabel

Serum amyloid A: a novel biomarker for endometrial cancer.

@ast

Serum amyloid A: a novel biomarker for endometrial cancer.

@en

P1433

Q33643221-37B90A32-37BC-4CED-A030-548848DEBB2B

P1476

Q33643221-D64984B5-41A9-4C04-93EF-E9975C5BECDE

P2093

Q33643221-0F84D9FC-B0D2-4451-93F3-9C671514818B

Q33643221-4B23FA05-11DC-4BD5-B164-EA761EB4307A

Q33643221-4E5F269E-E079-4BC1-8E93-7B9937916361

Q33643221-6D240F32-2980-4EDE-B589-DD059FDF3520

Q33643221-76A93875-6279-4AFB-ADCD-0749E044339F

Q33643221-841325B0-DACD-4D4E-A154-3F3661BA01B4

Q33643221-AB5A24E4-1B28-4EE7-9EFF-A6D026F3C678

Q33643221-C6746C64-6B86-46D1-BB89-58C4C0ABDC30

Q33643221-FBE4AA37-312C-4F04-8164-8D5286F1647B

Q33643221-FF5E8024-868C-4B3A-9508-1598DAFEC26C

P2860

Q33643221-05FF9923-09C4-4692-83CC-BCE8C5483DAA

Q33643221-0A968DE2-32C4-4459-83FF-AA95DEA93843

Q33643221-0B917EEE-B7A6-4275-AEFB-6653BAEF8B48

Q33643221-2D330490-D05A-4988-830E-3E9FADFD8E9A

Q33643221-3EDBF07D-9DF8-4F6A-ABDE-6AADED05215A

Q33643221-44403DC6-C5EC-4E5B-A453-9DD70382085B

Q33643221-4772D9B5-88B8-4A73-9DAF-5D7F23D45B3E

Q33643221-4C43D5EF-6592-4688-8488-59EDCF908DFA

Q33643221-55DDF55F-303C-430C-B151-0B23AB9F8847

Q33643221-5E509AF3-047D-4DAC-A17F-1F792AD5E7BC

P304

Q33643221-2161B958-62CF-4E17-8827-12AA7FF450C0

P31

Q33643221-F25F1616-D919-41D5-915A-EA91D3C6EA0D

P356

Q33643221-ADA99675-6AC5-49A8-9F34-64111C3A7600

P407

Q33643221-EA964074-74E1-4E58-82B5-2260B20A31DA

P433

Q33643221-5B7147B1-28C2-4659-821F-5E80B43FF492

P478

Q33643221-FF1BEF6B-CAFD-429F-90B3-3B6020BB8E72

P577

Q33643221-5F82781C-3106-459C-A384-40D4E79305C1

P5875

Q33643221-C423EFF5-F6CD-42AD-A1B1-CEE748DE0C77

P698

Q33643221-EA0B6C73-D0F6-4738-A14A-E1F58F520AD5

P921

Q33643221-1E8859D3-37EA-4BCE-855B-E1C33AB6657D

P932

Q33643221-C04D0031-FFC9-4905-84E8-A12D872A3FB9

P356

P1433

P1476

Serum amyloid A: a novel biomarker for endometrial cancer.

@en

P2093

Alessandro D Santin

http://www.w3.org/2001/XMLSchema#string

Emiliano Cocco

http://www.w3.org/2001/XMLSchema#string

Fattaneh A Tavassoli

http://www.w3.org/2001/XMLSchema#string

Karim El-Sahwi

http://www.w3.org/2001/XMLSchema#string

Marilisa Cargnelutti

http://www.w3.org/2001/XMLSchema#string

Natalia Buza

http://www.w3.org/2001/XMLSchema#string

Peter E Schwartz

http://www.w3.org/2001/XMLSchema#string

Sergio Pecorelli

http://www.w3.org/2001/XMLSchema#string

Stefania Bellone

http://www.w3.org/2001/XMLSchema#string

Thomas J Rutherford

http://www.w3.org/2001/XMLSchema#string

P2860

Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium

Cancer statistics, 2008

Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.

Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness.

Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states.

Serum protein markers for early detection of ovarian cancer

Preoperative CA 125 in endometrial cancer: is it useful?

Two pathogenetic types of endometrial carcinoma.

Preoperative serum CA-125 levels in treating endometrial cancer.

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy

P304

843-851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.24838

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40813233

http://www.w3.org/2001/XMLSchema#string

P698

20041483

http://www.w3.org/2001/XMLSchema#string

P921

P932

2819580

http://www.w3.org/2001/XMLSchema#string